Patent Portfolio

Neurotoxicity evaluation model system using diseased iPS cell, and use thereof

Ref. No. AJ157
Appl. No.
(filing date)
PCT/JP2018/017828(2018/5/8)
Pub. No.
(Pub. date)
WO2018/207789(2018/11/15)
Priority claim No.
(Priority date)

JP2017-093450 (2017/5/9)

Patent No.

-

Inventor INOUE Haruhisa, etc.
Assignee Kyoto University
Title of Invention Neurotoxicity evaluation model system using diseased iPS cell, and use thereof
Abstract

Provided is a method for evaluating the neurotoxicity of a compound by use of neurons differentiated from an iPS cell derived from a Charcot-Marie-Tooth disease (CMT) patient. This invention is based on a finding that the neurons from a CMT patient was more susceptible than neurons from a control subject, in terms of mitochondrial aggregation in a neurite after exposure to anti-cancer drugs which are known to cause neurotoxicity in humans.

Comments

-

Updated date 2018/12/18
Information
(External link)
https://www.j-platpat.inpit.go.jp/c1800/PU/WO-A-2018-207789/E90C2868C9861F7FBDA6E330186D953F74C7BF459D917D27E640CD6471A325EB/50/en
Tag